Divis Laboratories’ revenue in Q4FY18 grew by 2% yoy to Rs1,088cr. EBITDA grew by 6.8% yoy to Rs386.5cr in Q4FY18. EBITDA margins were at 35.5% in Q4FY18 vs. 31.4% in Q3FY18 vs. 33.9% in Q4FY17. PAT grew by 0.9% yoy to Rs261.6cr in Q4FY18.
The decline in the material cost was offset by higher employee cost.
Material cost declined 3.2% yoy to Rs407.6cr. As % of sales, material cost stood at 37.5% in Q4FY18 vs. 39.5% in Q4FY17.
Employee cost increased by 25.8% to Rs125.8cr. As % of sales, employee cost stood at 11.6% in Q4FY18 vs. 9.4% in Q4FY17.
Other expenses as % of sales stood at 15.4% in Q4FY18 vs. 17.2% in Q4FY17.
The company's Unit-1 at Choutuppal, Telangana State has cleared the general cGMP USFDA inspection in May 2018 without any observations.
The board has recommended a dividend of Rs 10/share.
Divis Laboratories Ltd is currently trading at Rs. 1,073.70, down by 18.3 points or 1.68% from its previous closing of Rs. 1,092 on the BSE.
The scrip opened at Rs. 1,095 and has touched a high and low of Rs. 1,095 and Rs. 1,060.10 respectively. So far 4,07,780 (NSE+BSE) shares were traded on the counter. The stock is currently trading above its 50 DMA.
Please use the temporary password sent on your email id or mobile no.
Update Mobile no.
Why you need to update your Mobile number ?
By providing verified mobile number we provide more exclusive information in the website.
Update Mobile no.
Terms & Conditions
By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in National Do Not Call Registry as laid down by Telecom Regulatory Authority of India will not be applicable for such information/ communication.